Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.

Literature DB >> 23561441

Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.

Qiurong Ding, Stephanie N Regan, Yulei Xia, Leoníe A Oostrom, Chad A Cowan, Kiran Musunuru.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2013 PMID： 23561441 PMCID： PMC3925309 DOI： 10.1016/j.stem.2013.03.006

Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633

× No keyword cloud information.

7 in total

1. A TALE nuclease architecture for efficient genome editing.

Authors: Jeffrey C Miller; Siyuan Tan; Guijuan Qiao; Kyle A Barlow; Jianbin Wang; Danny F Xia; Xiangdong Meng; David E Paschon; Elo Leung; Sarah J Hinkley; Gladys P Dulay; Kevin L Hua; Irina Ankoudinova; Gregory J Cost; Fyodor D Urnov; H Steve Zhang; Michael C Holmes; Lei Zhang; Philip D Gregory; Edward J Rebar
Journal: Nat Biotechnol Date: 2010-12-22 Impact factor: 54.908

2. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors: Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal: Science Date: 2012-06-28 Impact factor: 47.728

3. A TALEN genome-editing system for generating human stem cell-based disease models.

Authors: Qiurong Ding; Youn-Kyoung Lee; Esperance A K Schaefer; Derek T Peters; Adrian Veres; Kevin Kim; Nicolas Kuperwasser; Daniel L Motola; Torsten B Meissner; William T Hendriks; Marta Trevisan; Rajat M Gupta; Annie Moisan; Eric Banks; Max Friesen; Robert T Schinzel; Fang Xia; Alexander Tang; Yulei Xia; Emmanuel Figueroa; Amy Wann; Tim Ahfeldt; Laurence Daheron; Feng Zhang; Lee L Rubin; Lee F Peng; Raymond T Chung; Kiran Musunuru; Chad A Cowan
Journal: Cell Stem Cell Date: 2012-12-13 Impact factor: 24.633

4. Multiplex genome engineering using CRISPR/Cas systems.

Authors: Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal: Science Date: 2013-01-03 Impact factor: 47.728

5. RNA-guided human genome engineering via Cas9.

Authors: Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal: Science Date: 2013-01-03 Impact factor: 47.728

6. Genetic engineering of human pluripotent cells using TALE nucleases.

Authors: Dirk Hockemeyer; Haoyi Wang; Samira Kiani; Christine S Lai; Qing Gao; John P Cassady; Gregory J Cost; Lei Zhang; Yolanda Santiago; Jeffrey C Miller; Bryan Zeitler; Jennifer M Cherone; Xiangdong Meng; Sarah J Hinkley; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal: Nat Biotechnol Date: 2011-07-07 Impact factor: 54.908

7. RNA-programmed genome editing in human cells.

Authors: Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal: Elife Date: 2013-01-29 Impact factor: 8.140

7 in total

232 in total

Review 1. Human Germline Genome Editing.

Authors: Kelly E Ormond; Douglas P Mortlock; Derek T Scholes; Yvonne Bombard; Lawrence C Brody; W Andrew Faucett; Nanibaa' A Garrison; Laura Hercher; Rosario Isasi; Anna Middleton; Kiran Musunuru; Daniel Shriner; Alice Virani; Caroline E Young
Journal: Am J Hum Genet Date: 2017-08-03 Impact factor: 11.025

2. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.

Authors: Zengrong Zhu; Federico González; Danwei Huangfu
Journal: Methods Enzymol Date: 2014 Impact factor: 1.600

3. Genome editing in human stem cells.

Authors: Susan M Byrne; Prashant Mali; George M Church
Journal: Methods Enzymol Date: 2014 Impact factor: 1.600

4. Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection.

Authors: Joseph Ignatius Irudayam; Deisy Contreras; Lindsay Spurka; Aparna Subramanian; Jenieke Allen; Songyang Ren; Vidhya Kanagavel; Quoclinh Nguyen; Arunachalam Ramaiah; Kalidas Ramamoorthy; Samuel W French; Andrew S Klein; Vincent Funari; Vaithilingaraja Arumugaswami
Journal: Stem Cell Res Date: 2015-08-15 Impact factor: 2.020

Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.

1. A TALE nuclease architecture for efficient genome editing.

2. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

3. A TALEN genome-editing system for generating human stem cell-based disease models.

4. Multiplex genome engineering using CRISPR/Cas systems.

5. RNA-guided human genome engineering via Cas9.

6. Genetic engineering of human pluripotent cells using TALE nucleases.

7. RNA-programmed genome editing in human cells.

Review 1. Human Germline Genome Editing.

2. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.

3. Genome editing in human stem cells.

4. Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection.

Review 5. Hepatocyte Transplantation: Quo Vadis?

Review 6. Genome editing: a robust technology for human stem cells.

Review 7. CRISPR-Cas systems for editing, regulating and targeting genomes.

8. Treatment of β⁶⁵⁴ -thalassaemia by TALENs in a mouse model.

9. Highly Efficient CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.

10. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.